Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 26 | $11,844,247 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Aug 2024 18:03 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 16 Aug 2024 | Sale | 18,714 | 75.08 | 1,405,047 | D |
| 11 Mar 2024 20:31 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 11 Mar 2024 | Sale | 1,313 | 66.86 | 87,787 | D |
| 11 Mar 2024 20:31 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 11 Mar 2024 | Sale | 1,729 | 65.92 | 113,976 | D |
| 11 Mar 2024 20:31 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 11 Mar 2024 | Sale | 4,303 | 65.11 | 280,168 | D |
| 11 Mar 2024 20:31 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 07 Mar 2024 | Sale | 4,496 | 66.95 | 301,007 | D |
| 11 Mar 2024 20:31 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 07 Mar 2024 | Sale | 8,636 | 66.37 | 573,171 | D |
| 27 Feb 2024 19:58 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 26 Feb 2024 | Sale | 1,307 | 71.18 | 93,032 | D |
| 27 Feb 2024 19:58 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 26 Feb 2024 | Sale | 2,341 | 70.7 | 165,509 | D |
| 27 Feb 2024 19:58 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 26 Feb 2024 | Sale | 4,059 | 69.56 | 282,344 | D |
| 27 Feb 2024 19:58 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 26 Feb 2024 | Sale | 200 | 68.03 | 13,606 | D |
| 05 Feb 2024 18:07 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 02 Feb 2024 | Sale | 6,904 | 67.49 | 465,951 | D |
| 05 Feb 2024 18:07 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 02 Feb 2024 | Sale | 4,956 | 66.67 | 330,417 | D |
| 08 Nov 2023 17:31 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 06 Nov 2023 | Sale | 15,639 | 55.0174 | 860,417 | D |
| 08 Nov 2023 17:31 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 06 Nov 2023 | Sale | 26,754 | 55.9817 | 1,497,734 | D |
| 09 Aug 2023 18:05 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 07 Aug 2023 | Sale | 55,300 | 58.79 | 3,251,087 | D |
| 30 Mar 2023 17:08 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 28 Mar 2023 | Sale | 10,183 | 54.01 | 549,984 | D |
| 30 Mar 2023 17:08 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 28 Mar 2023 | Sale | 5,421 | 54.86 | 297,396 | D |
| 13 Mar 2023 19:35 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 13 Mar 2023 | Sale | 423 | 44.05 | 18,633 | D |
| 13 Mar 2023 19:35 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 13 Mar 2023 | Sale | 3,335 | 45.1 | 150,408 | D |
| 13 Mar 2023 19:35 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 10 Mar 2023 | Sale | 1,800 | 42.74 | 76,932 | D |
| 13 Mar 2023 19:35 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 10 Mar 2023 | Sale | 6,750 | 43.5 | 293,625 | D |
| 03 Mar 2023 19:03 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 01 Mar 2023 | Sale | 7,241 | 50.01 | 362,122 | D |
| 27 Feb 2023 20:03 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 24 Feb 2023 | Sale | 4,046 | 47.12 | 190,648 | D |
| 22 Feb 2023 20:05 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 21 Feb 2023 | Sale | 635 | 48.93 | 31,071 | D |
| 22 Feb 2023 20:05 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 21 Feb 2023 | Sale | 123 | 47.32 | 5,820 | D |
| 22 Feb 2023 20:05 | ITCI | Intra-Cellular Therapies Inc | NEUMANN MARK | EVP, Chief Commercial Officer | 21 Feb 2023 | Sale | 3,140 | 46.61 | 146,355 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)